...
首页> 外文期刊>Bangladesh Journal of Medical Science >Investigation of calcium metabolism in patients with coronary heart disease complicated by chronic heart failure, stage ii-a
【24h】

Investigation of calcium metabolism in patients with coronary heart disease complicated by chronic heart failure, stage ii-a

机译:冠心病并发慢性心力衰竭,ii-a期患者钙代谢的研究

获取原文

摘要

Objective: This study aims to to investigate calcium metabolism indices and bone mineralization in patients with coronary heart disease complicated by stage II-A chronic heart failure.Materials and Methods: The study involved 33 men with coronary heart disease (CHD) complicated by Stage II-A chronic heart failure (according to the classification by N.D. Strazhesko, V.H. Vasilenko and G.F. Lung (1935). Bone mineral density was measured using dual energy x-ray densitometry of lumbar region of spine. The level of 25-hydroxyvitamin D (25(ОН)D) has been detected by ELISA method using commercial Vitamin D3 screening kit (Switzerland). The level of ionized calcium was measuring by ion selective method using analyser of electrolytes AEK-01 (QuertiMed, Ukraine).Results and Discussion: Structural and functional changes of bone tissue of the lumbar spine have been found in 49,2 percent patients with coronary heart disease complicated by Stage II-A chronic heart failure, in particular, I stage of osteopenia – in 44,6 %, II stage of osteopenia – in 27,7 %, III stage of osteopenia – in 10,8 % and osteoporosis – in 16,9 %. It was established the same type of downward trend for BMD decreasing in L1 of patients with different stages of osteopenia, but in case of osteoporosis mineralization decreased equally in all vertebrae. The analysis of calcium metabolism indices indicate that concentration of ionized calcium significantly decreased in patients with CHD complicated by Stage II-A chronic heart failure vs control (1.26±0.02 mmol/l) by 11.1 % (I stage of osteopenia), 18.3 % (II stage of osteopenia) and 31.7 % (III stage of osteopenia). Similar tendency was observed towards concentration of 25(ОН)D.Conclusion: In patients with CHD complicated by Stage II-A chronic heart failure we have established statistically significant decrease in serum level of ionized calcium and 25-hydroxyvitamin D concentration. However, we didn’t find the relationship between serum calcium, 25-hydroxyvitamin D concentration and bone mineral density. Structural and functional changes of bone tissue of the lumbar spine have been found in 49,2 percent patients with coronary heart disease complicated by Stage II-A chronic heart failure. It was established the same type of downward trend for BMD decreasing in L1 of patients with different stages of osteopenia, but in case of osteoporosis mineralization decreased equally in all vertebrae.Bangladesh Journal of Medical Science Vol.17(3) 2018 p.395-401.
机译:目的:本研究旨在探讨合并II-A期慢性心力衰竭的冠心病患者的钙代谢指标和骨矿化。材料与方法:本研究涉及33例合并II期冠心病的男性-慢性心力衰竭(根据ND St​​razhesko,VH Vasilenko和GF Lung的分类(1935年)。使用双能量X射线密度计测量脊柱腰部的骨矿物质密度。25-羟基维生素D(25 (ELISA)使用市售的维生素D3筛查试剂盒(瑞士)通过ELISA法检测到,钙离子水平通过离子选择性法使用电解质分析仪AEK-01(乌克兰QuertiMed)测定。在49,2%患有II-A期慢性心力衰竭,特别是I期I期的冠心病患者中,发现腰椎骨组织的功能和功能改变骨质疏松症–占44.6%,II期骨质疏松症– 27.7%,III期骨质疏松症– 10.8%,骨质疏松症– 16.9%。骨质疏松症不同阶段的患者L1的BMD下降具有相同的下降趋势,但是在骨质疏松症的情况下,所有椎骨的矿物质下降均相同。钙代谢指标的分析表明,患有CHD并发II-A期慢性心力衰竭的CHD患者的离子钙浓度比对照组(1.26±0.02 mmol / l)显着降低11.1%(骨质减少的I期),降低18.3%(骨质减少的II期)和31.7%(骨质减少的III期)。对于25(ОН)D的浓度也观察到了类似的趋势。结论:在CHD并发II-A期慢性心力衰竭的患者中,我们已经确定了血浆中离子钙和25-羟基维生素D浓度的统计学下降。但是,我们没有发现血清钙,25-羟维生素D浓度与骨矿物质密度之间的关系。在49,2%患有II-A期慢性心力衰竭的冠心病患者中发现了腰椎骨组织的结构和功能变化。骨质疏松症不同阶段的患者L1的BMD下降具有相同类型的下降趋势,但骨质疏松症的矿物质在所有椎骨中均下降。孟加拉国医学杂志Vol.17(3)2018 p.395- 401。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号